679 |
FFR in the Bifurcation Treatment |
Farhat Fouladvand |
Apr. 21. 16 |
678 |
Hemodynamic Force and Coronary Plaque: Theoretical Evaluation of Mechanistic Effect |
Bon-Kwon Koo |
Apr. 21. 16 |
677 |
Coronary Blood Flow, Pressure and Resistance: How to Integrate, Interpret and Apply in Practice |
William F. Fearon |
Apr. 21. 16 |
676 |
Management of Stable Coronary Heart Disease with Objective Ischemia: COURAGE, FAME2 and Recent Meta-Analysis |
Gregg W. Stone |
Apr. 21. 16 |
675 |
SYNTAX-1, SYNTAX-II, SYNTAX-III: From Invasive to Non-Invasive Assessment of Coronary Stenosis |
Patrick W. Serruys |
Apr. 21. 16 |
674 |
New Findings from COLOR Registry |
Akiko Maehara |
Apr. 21. 16 |
673 |
Grand Vision for BRS Future: Natural History and Clinical Implication |
Patrick W. Serruys |
Apr. 21. 16 |
672 |
Pathological Insights II: Bioresorbable Scaffolds Implantation |
Aloke V. Finn |
Apr. 21. 16 |
671 |
The Critical Role of Lesion Preparation for BRS: Effects of Plaque Morphology, Components, and Novel Devices |
Giulio Guagliumi |
Apr. 21. 16 |
670 |
Imaging-Guidance for Bioresorbable Scaffolds Implantation |
Evelyn Regar |
Apr. 21. 16 |